Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Kaminski

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Cochrane Database of Systematic Reviews|December 14, 2012
Medical and surgical treatment for ocular myastheniaMichael Benatar, Henry Kaminski
Frontiers in Neurology|November 19, 2025
Ocular myasthenia gravis managementMark J Kupersmith, Gil I Wolfe, Henry Kaminski
Annals of the New York Academy of Sciences|September 29, 2011
Factors contributing to failure of neuromuscular transmission in myasthenia gravis and the special case of the extraocular musclesAlessandro Serra, Robert Ruff, Henry Kaminski, et al.
Neurology|December 3, 2011
Evidence-based guideline update: plasmapheresis in neurologic disordersHenry Kaminski, Gary Cutter, Robert L Ruff, et al.
Research Square|December 8, 2025
Proteomic and Machine Learning Analysis Predicts Treatment Response Signatures in Myasthenia GravisKarli Faith Gilbert, Amrita K Cheema, Henry Kaminski, et al.
JMIR Neurotechnology|July 12, 2023
A Digital Telehealth System to Compute the Myasthenia Gravis Core Examination MetricsMarc Garbey, Guillaume Joerger, Quentin Lesport, et al.
Health and Quality of Life Outcomes|September 5, 2020
Gender differences in quality of life among patients with myasthenia gravis in ChinaDong Dong, Marc Ka-Chun Chong, Yushan Wu, et al.
JAMA Network Open|April 13, 2026
Economic Evaluation of Thymectomy for the Treatment of Nonthymomatous Myasthenia GravisJoseph Lord, Matthew Walton, Peter Murphy, et al.
The Lancet. Neurology|November 19, 2020
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)Srikanth Muppidi, Jeffrey T Guptill, Saiju Jacob, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Cochrane Database of Systematic Reviews|December 14, 2012
Medical and surgical treatment for ocular myastheniaMichael Benatar, Henry Kaminski
Frontiers in Neurology|November 19, 2025
Ocular myasthenia gravis managementMark J Kupersmith, Gil I Wolfe, Henry Kaminski
Annals of the New York Academy of Sciences|September 29, 2011
Factors contributing to failure of neuromuscular transmission in myasthenia gravis and the special case of the extraocular musclesAlessandro Serra, Robert Ruff, Henry Kaminski, et al.
Neurology|December 3, 2011
Evidence-based guideline update: plasmapheresis in neurologic disordersHenry Kaminski, Gary Cutter, Robert L Ruff, et al.
Research Square|December 8, 2025
Proteomic and Machine Learning Analysis Predicts Treatment Response Signatures in Myasthenia GravisKarli Faith Gilbert, Amrita K Cheema, Henry Kaminski, et al.
JMIR Neurotechnology|July 12, 2023
A Digital Telehealth System to Compute the Myasthenia Gravis Core Examination MetricsMarc Garbey, Guillaume Joerger, Quentin Lesport, et al.
Health and Quality of Life Outcomes|September 5, 2020
Gender differences in quality of life among patients with myasthenia gravis in ChinaDong Dong, Marc Ka-Chun Chong, Yushan Wu, et al.
JAMA Network Open|April 13, 2026
Economic Evaluation of Thymectomy for the Treatment of Nonthymomatous Myasthenia GravisJoseph Lord, Matthew Walton, Peter Murphy, et al.
The Lancet. Neurology|November 19, 2020
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)Srikanth Muppidi, Jeffrey T Guptill, Saiju Jacob, et al.
Pageof 1